By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact bipartisan legislation that could lower drug prices by facilitating more free-market competition among generic and biosimilar medications.

The Trump administration is warning Harvard University that it could take over its patents, worth hundreds of millions of dollars, if a review finds the university hasn’t complied with federal law, an escalation of the continuing negotiations between the White House and America’s oldest university.

In a letter sent to Harvard President Alan M. Garber on Friday, Commerce Secretary Howard Lutnick alleges the university failed to follow several regulations outlined in federal law.